Some scholars have found that in cholangiocarcinoma xenograft tumors, stigmasterol can significantly reduce the expression of tumor necrosis factor-alpha (TNF-α) and inhibit further tumor angiogenesis after intervention, thus inhibiting tumor progression [70]. The gene discussed is TNF; the disease is cholangiocarcinoma.